These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8059561)

  • 21. [The reactogenicity and antigenic activity of a meningococcal group B vaccine made from a natural complex of the specific polysaccharide and outer membrane proteins].
    Basnak'ian IA; Alliluev AP; Kuvakina VI; Levina LA; Krasnoproshina LI; Kotel'nikova OV; Karabak VI; Mordvitskiĭ AM; Borovkova VM; Aleksakhina NN
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Dec; (12):50-5. PubMed ID: 2129147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two distinct outer membrane serotype subcomplexes of Neisseria meningitidis serogroup A.
    Bläsius R; Strittmatter W; Crowe B; Achtman M
    Infect Immun; 1990 Jun; 58(6):2008-10. PubMed ID: 2160438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
    Jennings HJ
    Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
    [No Abstract]   [Full Text] [Related]  

  • 24. [Evaluation of the immunological activity and safety of group B meningococcal vaccine prepared from a natural complex of specific polysaccharide and outer membrane proteins].
    Kuvakina VI; Golovina LI; Mishina AI; Skirda TA; Bobyleva GV; Mikheeva NG; Chernyshova TF; Temper RM; Ermolenko ZN
    Zh Mikrobiol Epidemiol Immunobiol; 2002; (2):33-7. PubMed ID: 12043150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surface antigen analysis of group B Neisseria meningitis outer membrane by monoclonal antibodies: identification of bactericidal antibodies to class 5 protein.
    Danelli MG; Batoreu NM; Lacerda MD; Ferreira CR; Cardoso JD; Peralta JM; Frasch CE
    Curr Microbiol; 1995 Sep; 31(3):146-51. PubMed ID: 7545046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of different routes of immunization using outer membrane vesicles of Neisseria meningitidis B and comparison of two adjuvants.
    Brito LT; Rinaldi FM; Gaspar EB; Correa VA; Gonçalves CA; Portilho AI; Trzewikoswki de Lima G; De Gaspari E
    Vaccine; 2020 Nov; 38(48):7674-7682. PubMed ID: 33082014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Primary and secondary immune response of mice to polysaccharide antigens of meningococcal serogroups A and C].
    Mokrenko AI
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Apr; (4):72-8. PubMed ID: 6773274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological relationship between the capsular polysaccharides of Neisseria meningitidis serogroups Z and 29E.
    Griffiss JM; Brandt BL
    J Gen Microbiol; 1983 Feb; 129(2):447-52. PubMed ID: 6405009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A vaccine carrier derived from Neisseria meningitidis with mitogenic activity for lymphocytes.
    Liu MA; Friedman A; Oliff AI; Tai J; Martinez D; Deck RR; Shieh JT; Jenkins TD; Donnelly JJ; Hawe LA
    Proc Natl Acad Sci U S A; 1992 May; 89(10):4633-7. PubMed ID: 1533934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complement-mediated bactericidal activity of human antibodies to poly alpha 2-->8 N-acetylneuraminic acid, the capsular polysaccharide of Neisseria meningitidis serogroup B.
    Mandrell RE; Azmi FH; Granoff DM
    J Infect Dis; 1995 Nov; 172(5):1279-89. PubMed ID: 7594665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral immunization with a Streptococcal pneumoniae polysaccharide conjugate vaccine in enterocoated microparticles induces serum antibodies against type specific polysaccharides.
    Flanagan MP; Michael JG
    Vaccine; 1999 Jan; 17(1):72-81. PubMed ID: 10078610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of the conditions for Neisseria meningitidis cultivation on the protein composition in the protein-polysaccharide complex--the base of meningococcal serogroup B vaccine].
    Kuvakina VI; Basnak'ian IA; Aleksakhina NN; Artiukhova II; Bobyleva GV; Omarova SM
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (2):60-3. PubMed ID: 8701659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Meningococcal Outer Membrane Vesicle Vaccine with Overexpressed Mutant FHbp Elicits Higher Protective Antibody Responses in Infant Rhesus Macaques than a Licensed Serogroup B Vaccine.
    Beernink PT; Vianzon V; Lewis LA; Moe GR; Granoff DM
    mBio; 2019 Jun; 10(3):. PubMed ID: 31213564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thymic-dependence and immune memory in mice vaccinated with meningococcal polysaccharide group B complexed to outer membrane protein.
    Moreno C; Esdaile J; Lifely MR
    Immunology; 1986 Mar; 57(3):425-30. PubMed ID: 3082745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody studies in mice of outer membrane antigens for use in an improved meningococcal B and C vaccine.
    Milagres LG; Cristina M; Brandileone MC; Sacchi CT; Vieira VS; Zanella RC; Frasch CE
    FEMS Immunol Med Microbiol; 1996 Jan; 13(1):9-17. PubMed ID: 8821393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistence of antibodies to meningococcal IgA1 protease versus decay of antibodies to group A polysaccharide and Opc protein.
    Thiesen B; Greenwood B; Brieske N; Achtman M
    Vaccine; 1997 Feb; 15(2):209-19. PubMed ID: 9066040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune response to native NadA from Neisseria meningitidis and its expression in clinical isolates in Brazil.
    Fukasawa LO; Gorla MCO; Lemos APS; Schenkman RPF; Brandileone MCC; Fox JW; Raw I; Frasch CE; Tanizaki MM
    J Med Microbiol; 2003 Feb; 52(Pt 2):121-125. PubMed ID: 12543917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A quantitative ELISA for antigen-specific IgG subclasses using equivalence dilutions of anti-kappa and anti-subclass specific secondary reagents. Application to the study of the murine immune response against the capsular polysaccharide of Neisseria meningitidis serogroup B.
    Colino J; Diez M; Outschoorn I
    J Immunol Methods; 1996 Apr; 190(2):221-34. PubMed ID: 8621957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Vaccines against Neisseria meningitidis].
    Ferrón L; Criado MT; Ferreirós CM
    Enferm Infecc Microbiol Clin; 1992 May; 10(5):296-301. PubMed ID: 1391002
    [No Abstract]   [Full Text] [Related]  

  • 40. Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children.
    Käyhty H; Ahman H; Rönnberg PR; Tillikainen R; Eskola J
    J Infect Dis; 1995 Nov; 172(5):1273-8. PubMed ID: 7594664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.